Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN56652283
ISRCTN56652283
Completed
Phase 2

Randomized phase II Trial of combined chemoradiation with Epidermal Growth Factor Receptor (EGFR) antagonist Cetuximab versus combined chemoradiation with EGFR antagonist Cetuximab and sequential Cetuximab for patients with locally advanced pancreatic adenocarcinoma

niversity of Heidelberg (Germany)0 sites66 target enrollmentJune 13, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Heidelberg (Germany)
Enrollment
66
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Study protocol in http://www.ncbi.nlm.nih.gov/pubmed/16219105

Registry
who.int
Start Date
June 13, 2005
End Date
December 31, 2007
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Heidelberg (Germany)

Eligibility Criteria

Inclusion Criteria

  • •Patients with locally advanced primary inoperable pancreatic cancer

Exclusion Criteria

  • •1\. Active infection
  • •2\. Liver function impairment
  • •3\. Pregnancy
  • •4\. Breast feeding
  • •5\. Metastatic disease
  • •6\. Elevated serum calcium level
  • •7\. Other severe systemic disease
  • •8\. Second malignancy (except carcinoma in situ of the cervix uteri, basal cell carcinoma of the skin after adequate oncologic treatment)
  • •9\. Any other experimental treatment four weeks before study inclusion
  • •10\. Known positive HACA (Human Anti\-Chimeric Antibody)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
Phase 2
Concurrent Chemoradiotherapy with Nimotuzumab for High Risk Nasopharyngeal CarcinomaNasopharyngeal Carcinoma
NCT04223024Sun Yat-sen University246
Completed
Phase 2
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung CancerAdenosquamous Lung CarcinomaBronchioloalveolar CarcinomaLarge Cell Lung CarcinomaLung AdenocarcinomaNon-Small Cell Lung CarcinomaRecurrent Non-Small Cell Lung CarcinomaSquamous Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer
NCT02186847NRG Oncology170
Withdrawn
Phase 2
Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive WomenCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedFIGO Stage IIB Cervix CarcinomaFIGO Stage III Cervix CarcinomaFIGO Stage IVA Cervix CarcinomaHIV Infection
NCT03834571AIDS Malignancy Consortium
Completed
Phase 2
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical CancerCervical Cancer
NCT02635360Linda R Duska94
Recruiting
Phase 2
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCTCentral Nervous System Nongerminomatous Germ Cell TumorChoriocarcinomaEmbryonal CarcinomaImmature TeratomaMalignant TeratomaMixed Germ Cell TumorPineal Region Germ Cell TumorPineal Region Immature TeratomaPineal Region Yolk Sac TumorSuprasellar Germ Cell Tumor
NCT04684368Children's Oncology Group160